Charles Divita III - 10 Sep 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
10 Sep 2025
Net transactions value
-$127,435
Form type
4
Filing time
11 Sep 2025, 16:04:10 UTC
Previous filing
11 Jun 2025
Next filing
11 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DIVITA CHARLES III CHIEF EXECUTIVE OFFICER, Director C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, FLOOR 17, NEW YORK /s/ Adam C. Vandervoort, Attorney-in-Fact 11 Sep 2025 0001347535

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +39,160 +25% 195,801 10 Sep 2025 Direct F1
transaction TDOC Common Stock Sale $127,435 -16,787 -8.6% $7.59 179,014 11 Sep 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -39,160 -12% $0.000000 274,123 10 Sep 2025 Common Stock 39,160 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3 On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.